MYnD Analytics Gets Breakthrough Tag for Mental Health Decision Support Tool
/Congrats to MYnD Analytics and Mind Therapy Clinic’s Dr. Schiller!
Brief:
The FDA has awarded breakthrough device designation to a MYnD Analytics' technology that identifies the medications most likely to work in patients with mental health conditions.
MYnD's technology, PEER 4.0, works by comparing the brain activity of a patient to those of people with similar patterns to zero in on the drugs that have worked in analogous situations in the past.
The breakthrough designation positions MYnD to receive more support from the FDA and a faster review.